Edobacomab
Alternative Names: E5; Promune-E5; Xomen-E5Latest Information Update: 18 Aug 2009
At a glance
- Originator XOMA
- Class Antibacterials; Antitoxins; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gram-negative infections; Septic shock
Most Recent Events
- 28 Jun 1999 Discontinued-preregistration for Septic shock in European Union (IV)
- 28 Jun 1999 Discontinued-preregistration for Septic shock in Japan (IV)
- 04 Aug 1997 Discontinued-preregistration for Septic shock in USA (IV)